Evaluating the effects of mitochondrial autophagy flux on ginsenoside Rg2 for delaying D-galactose induced brain

Jun-Jie Zhang1, Ke-Cheng Chen2, Yue Zhou1

  • 1College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China; National & Local Joint Engineering Research Center for Ginseng Breeding and Development, Changchun 130118, China.

Abstract

Insights

Ginsenoside Rg2 (Rg2) effectively combats D-galactose-induced brain aging in mice by improving memory and promoting mitochondrial autophagy. This study highlights Rg2

Area of Science:

  • Neuroscience
  • Gerontology
  • Pharmacology

Background:

  • Aging accelerates neurodegeneration, with ginsenosides from Panax ginseng showing anti-aging properties.
  • Ginsenoside Rg2 (Rg2), a panaxatriol-type ginsenoside, exhibits notable neuroprotective effects.

Purpose of the Study:

  • To investigate the therapeutic potential and molecular mechanisms of Rg2 in a mouse model of subacute brain aging.
  • To evaluate Rg2's effects on cognitive function and brain pathology induced by D-galactose (D-gal).

Main Methods:

  • Established a D-gal-induced brain aging model in mice.
  • Assessed cognitive function using the Morris water maze (MWM).
  • Analyzed brain histopathology, protein expression (p53, p21, p16ink4α, autophagy markers), and mitochondrial ultrastructure via TEM and Western blot.

Main Results:

  • Rg2 treatment reversed D-gal-induced memory deficits, cognitive dysfunction, and redox imbalance.
  • Rg2 reduced levels of aging-related proteins (p53, p21, p16ink4α) and D-gal-induced pathological brain changes.
  • Rg2 promoted autophagy flux by degrading p62 and enhanced mitochondrial function via LAMP2/TFEB upregulation.

Conclusions:

  • Rg2 postpones brain aging by enhancing mitochondrial autophagy and maintaining mitochondrial function.
  • These findings expand the understanding of ginsenosides' pharmacological activities in delaying brain aging.